News Update

EV Revolution: Lessons for India to learn from US and China!London court green-signals auction of luxury apartment of fugitive Nirav ModiGovt consults RBI; finalises borrowing plan for first half of FY 2024-25Gadkari says Farmers’ protest is politically-motivatedVP calls upon women entrepreneurs to be 'Vocal for Local'America offers USD 10 mn bounty for information on ‘Blackcat’ hackers after UnitedHealth gets hitI-T- The order of the ITSC can only be reopened in cases of fraud or misrepresentation: HC8 persons including Hezbollah militants killed in Israeli strike on LebanonI-T - Income so surrendered on account of investment in excess stock during course of survey cannot be brought to tax under deeming provisions of section 69B: ITATMacron pillories EU-South Africa trade deal; calls it ‘really bad’ in BrazilI-T-Power of revision need not be exercised where facts do not reveal any lack of enquiry by AO into relevant issue & when twin requirements of order being erroneous as well as prejudicial to Revenue's interests, are not satisfied: ITATThailand’s Lower House okays Bill to legitimise same-sex marriageI-T -Penalty u/s 271(1)(c) cannot be imposed where an assessee claims deduction u/s 80P while being ineligible therefor, but being under the bona fide impression of being eligible for such benefit : ITATYellen warns China against clean energy dumpingCus - Enhancement of declared value of imported goods is not tenable, where Department adduces no material to show how the enhanced value was computed & where no cogent rationale is made out for rejecting declared value: CESTATMilky Way’s central black hole - Twisted magnetic field observedCus - Assessee has not proved beyond reasonable doubt that goods in question imported under air way bills/bills of entry were in fact filed by him and hence the only natural corollary available to Revenue is confiscation of same: CESTATSmall investors help Trump Media’s valuation skyrocket to USD 13 billionST - When the facts are in the knowledge of department subsequent SCN alleging suppression cannot be issued and entire demand was found beyond normal period of limitation: CESTATFM Nirmala Sitharaman declines to contest LS elections as she has no fundsST - Tripura State Rifles not required to pay Service Tax under heading of Security Services, as it is is not engaged in business of providing security services: CESTATJustice Ritu Raj Awasthi joins as Judicial member of LokpalCX - Clandestine removal alleged based on consumption of raw inputs and heightened electricity usage - Tax demands based on third party statements but without permitting cross examination of deponents; case remanded to allow this exercise: CESTAT
 
Niti Aayog outlines investment opportunities in India's healthcare sector

By TIOL News Service

NEW DELHI, MAR 30, 2021: GOVERNMENT think tank Niti Aayog on Tuesday released a report outlining the range of investment opportunities in various segments of India's healthcare sector, including hospitals, medical devices and equipment, health insurance, telemedicine, home healthcare and medical value travel.

India's healthcare industry has been growing at a Compound Annual Growth Rate (CAGR) of around 22 per cent since 2016, employing 4.7 million people directly. At this rate, it is expected to reach USD 372 billion in 2022 and add 2.7 million jobs.

"Healthcare has become one of the largest sectors of the Indian economy, in terms of both revenue and employment," said Niti Aayog's CEO Mr Amitabh Kant.

Several factors are driving the growth of the sector, including an aging population, a growing middle class, the rising proportion of lifestyle diseases, an increased emphasis on public-private partnerships as well as accelerated adoption of digital technologies, besides heightened interest and increased Foreign Direct Investment (FDI) inflows.

"The COVID-19 pandemic has not only presented challenges but also several opportunities for India to grow. All these factors, together make India's healthcare industry ripe for investment," Mr Kant said.

The report provides an overview of India's healthcare sector, including insights about its employment generation potential, the prevailing business and investment climate as well as the overarching policy landscape.

In the hospital segment, the expansion of private players to Tier-2 and Tier-3 locations, beyond metropolitan cities, offers an attractive investment opportunity. According to Invest India's Investment Grid, there are nearly 600 investment opportunities worth USD 32 billion (Rs 2.3 lakh crore) in the country's hospital and medical infrastructure sub-sector.

With respect to pharmaceuticals, India can boost domestic manufacturing, supported by the government's Production Linked Incentive (PLI) scheme alongside offering investment avenues in segments like contract manufacturing and research, over-the-counter drugs and vaccines. Further, between 2018 and 2024, patents worth USD 251 billion are expected to expire globally, presenting a lucrative opportunity for the country's pharmaceutical sector, including the patent market

In the medical devices and equipment segment, expansion of diagnostic and pathology centres as well as miniaturised diagnostics have high potential for growth. Further, medical value travel, especially wellness tourism, has bright prospects, given India's inherent strengths in alternative systems of medicine.

Technology advancements such as Artificial Intelligence (AI), wearables and other mobile technologies, along with Internet of Things (IoT), also offer numerous avenues for investment.


POST YOUR COMMENTS
   

AR not Afar by SK Rahman

TIOL Tube Latest

Shri Shailendra Kumar, Trustee, TIOL Trust, giving welcome speech at TIOL Awards 2023




Shri M C Joshi, Former Chairman, CBDT




Address by Shri Buggana Rajendranath, Hon'ble Finance Minister of Andhra Pradesh at TIOL Awards 2023